Skip to content

{ Category Archives } Research

Technology and Robotics in Rehabilitation

The growing use of robotic technology in neurorehabilitation promises a brighter future for patients who have residual deficits from their neurological insult. MossRehab is today a center of research and therapeutic use of rehabilitation interventions that make use of robotic devices for patients with stroke and traumatic brain injury. “The rationale for using robots in [...]

MossRehab Conducting Exclusive U.S. Trial of ReWalk

MossRehab is the exclusive site in the U.S. for clinical trials of ReWalk™, the first commercially viable upright device that enables wheelchair users to stand, walk, and climb stairs. In July, two individuals with spinal cord injuries demonstrated the use of ReWalk at MossRehab’s Gain and Motion Analysis Lab, moving independently from a wheelchair to [...]

Research Study: Walking Therapy for Patients with Traumatic Brain Injury

A study is being conducted by MossRehab to compare two types of walking training to help people who have had brain injuries and are having difficulty walking. For more information, view the flyers posted below or contact Stella Kim, the Co-Investigator at (215) 663-6665 or kimst@einstein.edu. This study is approved by the Institutional Review Board of [...]

Scholarly Update

Linebarger, MC, Romania, JR, Fink, RB, Bartlett, M, & Schwartz, MF (2008) Building on residual speech: A portable processing prosthesis for aphasia. Journal of Rehabilitation Research and Development 45:9, 1401-1414. Schnur, TT, Schwartz, MF, Kimberg, D., Hirshorn, E, Coslett, HB, Thompson-Schill, SL (2009) Localizing interference during naming: convergent neuroimaging and neuropsychological evidence for the function [...]

Open Patient Enrollment for MossRehab Trials

ZolpidemPrincipal Investigator: John Whyte, MD, PhD Trial location: MossRehab   This trial seeks to define more precisely the proportion of patients in the vegetative and minimally conscious states (VS/MCS) who have a clinically meaningful response to zolpidem with improvement in their level of consciousness. It will use cutting-edge research methods (functional neuroimaging, event related potentials, [...]

MossRehab Implements New Clinical Ladder Program for Therapists

MossRehab has rolled out a newly developed Clinical Ladder Program that supports and promotes speech, occupational, physical, and recreation therapists who want to develop professionally. A Clinical Ladder that recognized years of experience had existed previously, but it did not adequately recognize therapists’ accomplishments, areas of expertise or specialization, or their work in the larger [...]

A Cross-National Comparison of TBI Outcomes

Since the 1980s, the United States has seen a gradual decline in the duration and intensity of treatment for traumatic brain injury (TBI). Largely a response to economic pressures, this trend has raised the question of whether shortened, less intensive TBI treatment adversely affects patient outcomes. A definitive answer may soon be found through a [...]

In Theory and Practice: Moss Rehabilitation Research Institute

For many rehab providers, research remains secondary to treatment. Scientific inquiry—both time-consuming and expensive—must be relegated to the background due to the enormous demands of the clinic. At MossRehab, however, a team devoted entirely to research operates within the infrastructure of the rehabilitation hospital. Collectively called the Moss Rehabilitation Research Institute (MRRI), these researchers work [...]

MossRehab to Perform Exclusive U.S.Trial of ReWalk(TM)

MossRehab will soon begin the exclusive U.S. clinical trial for a new assistive technology called the ReWalk. The ReWalk is a motorized exoskeleton suit that enables patients with lower limb disabilities, including complete paralysis, to independently engage in ambulatory activities, such as standing, walking and in some cases climbing stairs.The ReWalk consists of a lightweight [...]

Interventional Therapy: Intrathecal Therapy Trials With Ziconotide

by David Caraway, MD, PhD; Michael Saulino, MD, PhD; Robert Fisher, MD The 2007 Polyanalgesic Consensus Panel recommends ziconotide as one of three options for first-line intrathecal (IT) monotherapy. As we all know, Medicare and most insurance companies require a trial of IT therapy before one can proceed with implantation of a delivery system. Unlike [...]

Interventions in Chronic Pain Management. 6. Interventional Approaches to Chronic Pain Management

by E. Anthony Overton, DO, Ira D. Kornbluth, MD, Michael F. Saulino, MD, Michele Y. Holding, MD, Mitchell K. Freedman, DO This self-directed learning module highlights strategies for interventional treatments for chronic pain disorders. It is part of the chapter on chronic pain in the Self-Directed Physiatric Education Program for practitioners in physical medicine and [...]

Interventions in Chronic Pain Management. 5. Approaches to Medication and Lifestyle in Chronic Pain Syndromes

by Mitchell K. Freedman, DO, Michael F. Saulino, MD, E. Anthony Overton, DO, Michele Y. Holding, MD, Ira D. Kornbluth, MD This self-directed learning module first reviews the importance of weight management and smoking cessation in the treatment of axial low back pain and then describes the use of medication in complex regional pain syndrome [...]